Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens With Other PI's/NNRTI's in HIV+ Children and Adolescents With Elevated Lipid Levels.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; HIV protease inhibitors; Non-nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Oct 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 21 Oct 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2016 as per ClinicalTrials.gov record.